MedTrace Logo

Data Registry Following Patients Using Supera Stent in the Femoral Arteries

NCT01154751 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-09-19

Study results available
· View outcomes & findings →

Summary

Long-term, observational, prospective, multicenter registry following patients who have been implanted with the SUPERA Interwoven Self-Expanding Nitinol Stent for treating stenosis in the superficial femoral and/or femoropopliteal arteries.

Conditions

Interventions

DEVICE

SUPERA Interwoven self-expanding nitinol stent

Insertion of stent at stenotic area

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Thomas Zeller, Prof Dr med · Herzzentrum Abteilung fur Angiologie, Bad Krozingen, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2012-08-31
Completion
2015-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01154751 on ClinicalTrials.gov